NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Purple Biotech Ltd (TA: PPBT)

 
PPBT Technical Analysis
5
As on 11th Jun 2023 PPBT STOCK Price closed @ 61.10 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 93.96 & Strong Sell for SHORT-TERM with Stoploss of 112.34 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

PPBTSTOCK Price

Open 61.60 Change Price %
High 62.00 1 Day -4.10 -6.29
Low 60.30 1 Week -4.50 -6.86
Close 61.10 1 Month -9.30 -13.21
Volume 34820 1 Year -63.30 -50.88
52 Week High 133.30 | 52 Week Low 50.80
 
TA Israel Most Active Stocks
TA125 2008.05 1.06%
BEZQ 472.70 -0.06%
GLEX 8.50 10.39%
CANF 3.20 -3.03%
GIVO-L 47.30 0.00%
LUMI 2815.00 1.26%
ELAL 394.00 3.55%
GNRS 78.90 1.41%
BLRX 37.60 -2.08%
TDGN-L 171.50 17.55%
 
TA Israel Top Gainers Stocks
NXTG 93.80 133.33%
MCTC 95.00 90.00%
EMTC 61.90 34.57%
TDGN-L 171.50 17.55%
NALA 67.00 16.12%
SEFA 67.00 16.12%
SEFA 67.00 16.12%
HROD 51.30 14.00%
NOST 601.90 12.25%
ARDM 37.70 12.20%
 
TA Israel Top Losers Stocks
KMNK 51.00 -23.19%
ULTR 74.10 -16.74%
MEAT 0.77 -9.41%
MEAT 0.77 -9.41%
AVRT 56.90 -8.96%
CHR 68.10 -8.59%
CHR 68.10 -8.59%
CHR 68.10 -8.59%
CHR 68.10 -8.59%
CHR 68.10 -8.59%
 
 
PPBT
Daily Charts
PPBT
Intraday Charts
Whats New @
Bazaartrend
PPBT
Free Analysis
 
PPBT Important Levels Intraday
RESISTANCE64.38
RESISTANCE63.33
RESISTANCE62.68
RESISTANCE62.03
SUPPORT60.17
SUPPORT59.52
SUPPORT58.87
SUPPORT57.82
 
PPBT Forecast May 2024
4th UP Forecast160.92
3rd UP Forecast128.91
2nd UP Forecast109.12
1st UP Forecast89.33
1st DOWN Forecast32.87
2nd DOWN Forecast13.08
3rd DOWN Forecast-6.71
4th DOWN Forecast-38.72
 
PPBT Weekly Forecast
4th UP Forecast91.93
3rd UP Forecast82.04
2nd UP Forecast75.93
1st UP Forecast69.82
1st DOWN Forecast52.38
2nd DOWN Forecast46.27
3rd DOWN Forecast40.16
4th DOWN Forecast30.27
 
PPBT Forecast2024
4th UP Forecast224.7
3rd UP Forecast172.23
2nd UP Forecast139.8
1st UP Forecast107.37
1st DOWN Forecast14.83
2nd DOWN Forecast-17.6
3rd DOWN Forecast-50.03
4th DOWN Forecast-102.5
 
 
PPBT Other Details
Segment EQ
Market Capital 24996818944.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
PPBT Address
PPBT
 
PPBT Latest News
 
Your Comments and Response on Purple Biotech Ltd
 
PPBT Business Profile
Purple Biotech Ltd. is a clinical-stage company focused on advancing therapies to overcome tumor immune evasion and drug resistance to create treatments for cancer patients in the United States. It operates through two segments, Oncology, and Pain and Hypertension. The company's marketed products include Consensi, a fixed-dose combination of celecoxib and amlodipine besylate for the simultaneous treatment of osteoarthritis pain and hypertension. Its oncology pipeline includes NT219, a small molecule that targets insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment of recurrent and/or metastatic solid tumors and squamous cell carcinoma of the head and neck cancer; and CM24, a monoclonal antibody blocking CEACAM1 that is being developed as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer and pancreatic cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. Purple Biotech Ltd. was founded in 2010 and is headquartered in Rehovot, Israel. Address: 4 Oppenheimer Street, Rehovot, Israel, 7670104
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service